Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001315736 | SCV001506326 | uncertain significance | Methylmalonic aciduria and homocystinuria type cblD | 2024-11-11 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 138 of the MMADHC protein (p.Glu138Asp). This variant is present in population databases (rs113390214, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with MMADHC-related conditions. ClinVar contains an entry for this variant (Variation ID: 1016695). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt MMADHC protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001315736 | SCV002083920 | uncertain significance | Methylmalonic aciduria and homocystinuria type cblD | 2020-01-24 | no assertion criteria provided | clinical testing |